Company:  PACIRA BIOSCIENCES, INC. (PCRX)
Form Type:  10-Q
Filing Date:  8/8/2019 
CIK:  0001396814 
Address:  5 SYLVAN WAY
SUITE 300
 
City, State, Zip:  PARSIPPANY, New Jersey 07054 
Telephone:  973-254-3560 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$42.99  
Change: 
0.07 (0.16%)  
Trade Time: 
02:26 PM EST  
Market Cap: 
$1.79B
Trade PCRX now with 

© 2019  
Description of Business
Pacira Pharmaceuticals, Inc., a Delaware corporation, is the holding company for our California operating subsidiary of the same name, or Pacira California. In March 2007, we acquired Pacira California from SkyePharma Holdings, Inc. (now a subsidiary of Vectura Group plc), or Skyepharma (referred to in this Annual Report on Form 10-K as the "Skyepharma Acquisition"). Unless the context requires otherwise, references to "Pacira," "we," the "Company," "us" and "our" in this Annual Report on Form 10-K refers to Pacira Pharmaceuticals, Inc., a Delaware corporation, and its subsidiaries. Corporate Information We were incorporated in Delaware under the name Blue Acquisition Corp. in December 2006 and changed our name to Pacira, Inc. in June 2007. In October 2010, we changed our name to Pacira Pharmaceuticals, Inc. Our principal executive offices are in Parsippany, New Jersey. Pacira®, EXPAREL®, DepoFoam®, DepoCyt® (United States (U.S.
Register and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      Item 1. FINANCIAL STATEMENTS (Unaudited)
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
          INCOME STATEMENT
      Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      FINANCIAL STATEMENTS
        CASH FLOW
      Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      Item 4. CONTROLS AND PROCEDURES
    PART II - OTHER INFORMATION
      Item 1. LEGAL PROCEEDINGS
      Item 1A. RISK FACTORS
      Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF ...
      Item 3. DEFAULTS UPON SENIOR SECURITIES
      Item 4. MINE SAFETY DISCLOSURES
      Item 5. OTHER INFORMATION
      Item 6. EXHIBITS
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. §1350